Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Hyperfractionated accelerated radiotherapy"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Terje Osnes, Bianca Lorntzsen, Krystyna Kotanska Grøholt, Eva Sigstad, Anne-Birgitte Jacobsen
Publikováno v:
Anticancer Research. 40:6979-6985
Background/aim This study aimed to examine survival and surgical complications in patients with anaplastic thyroid cancer (ATC) after multimodal treatment. Patients and methods Since 2002, the recommended treatment strategy for ATC at our centre has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af5fd5ab7b0fc433bface4af78920a9b
https://doi.org/10.21873/anticanres.14722
https://doi.org/10.21873/anticanres.14722
Publikováno v:
Leukemialymphoma. 61(6)
Patients with chemotherapy-refractory non-Hodgkin lymphoma (NHL) have a poor prognosis with a median overall survival (OS) of only 10 months. To investigate the role of radiotherapy (RT) in such patients, we conducted a retrospective review of 17 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aceba06740188b52cb1fd992795a6be4
https://pubmed.ncbi.nlm.nih.gov/32102580
https://pubmed.ncbi.nlm.nih.gov/32102580
Publikováno v:
Clinical Lung Cancer. 19(3):199-212
Stereotactic ablative body radiotherapy (SABR) is popular because of the high rates of local control with low toxicity seen in lung cancer patients. In this study we compared clinically significant toxicity and overall survival for SABR and non-SABR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od________83::49c7088081519755c09fc744096b0247
https://doi.org/10.1016/j.cllc.2017.11.006
https://doi.org/10.1016/j.cllc.2017.11.006
Publikováno v:
Clinical Lung Cancer. 19:199-212
Stereotactic ablative body radiotherapy (SABR) is popular because of the high rates of local control with low toxicity seen in lung cancer patients. In this study we compared clinically significant toxicity and overall survival for SABR and non-SABR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23ef0fb340947ebccbedfbe38e1d5670
https://doi.org/10.1016/j.cllc.2017.11.006
https://doi.org/10.1016/j.cllc.2017.11.006
Autor:
Marlene Hechtner, Jochem König, Michael Baumann, Susanne Singer, Beate Hornemann, Mechthild Krause, Steffen Appold
Publikováno v:
Radiotherapy and Oncology. 126:283-290
Background and purpose To evaluate the quality of life (QoL) of patients with inoperable non-small cell lung cancer treated with conventionally fractionated radiotherapy (CF) vs. continuous hyperfractionated accelerated radiotherapy weekend-less (CHA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7559a7f639d4aaad2368d5ba389a5c65
https://doi.org/10.1016/j.radonc.2017.12.005
https://doi.org/10.1016/j.radonc.2017.12.005
Autor:
Rasul Sharifov, Serap Yucel, Esra Kaytan-Saglam, Cetin Ordu, Oktar Asoglu, Zeynep Güral, Semen Onder, Hediye Acun, Sezer Saglam, Ethem Nezih Oral, Ahmet Kizir
Publikováno v:
World Journal of Gastrointestinal Oncology
AIM To evaluate the efficacy and tolerability of neoadjuvant hyperfractionated accelerated radiotherapy (HART) and concurrent chemotherapy in patients with locally advanced infraperitoneal rectal cancer. METHODS A total of 30 patients with histopatho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a4943d7086cc940fb55196d88f3b72b
https://doi.org/10.4251/wjgo.v10.i1.40
https://doi.org/10.4251/wjgo.v10.i1.40
Autor:
Naoki Yamanaka, Yoshio Hishikawa, Masayuki Fujiwara, S. Harui, H. Yokoyama, Yanagi H, Norihiko Kamikonya, Hiroshi Doi, A. Kakuno
Publikováno v:
Radiotherapy and Oncology. 161:S1049
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3efcf58edbf2b3792b471fd75423e2e5
https://doi.org/10.1016/s0167-8140(21)07721-5
https://doi.org/10.1016/s0167-8140(21)07721-5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.